Trending Now
LeafDraft — daily expert insights on technology, finance & world news
500
Articles published
11
Topics covered
85.8K
Articles read
Nuclear Clocks Poised to Eclipse Atomic Timekeeping
Researchers are developing nuclear clocks—timekeepers based on nuclear energy levels rather than electronic transitions—that promise orders-of-magnitude improvements in stability and new tests of fundamental physics. This feature explains how they work, why they could replace atomic clocks, the technical hurdles ahead, and what practical uses might follow.
Francesco
Oct 12, 2026
Most Read
by our readers- 1
How Shorthand Beat Typing: Masters Reached 280 WPM
Technology• 8 min
1.3K22 - 2
BDNF and Breaking Bad Habits: The Brain Chemical That Helps
Science• 8 min
1.2K29 - 3
Scientists Identify New Alzheimer’s Trigger — Drug That Blocks It
Health• 8 min
1.2K30 - 4
New Haircut Without Side Bangs? How to Know and Fix It
Lifestyle• 8 min
1.1K27 - 5
Constipation Drug Prucalopride May Clear Depression Brain Fog
Health• 8 min
1K27
Shortcut to Fusion Energy: What a New Breakthrough Could Mean
Scientists report a potential shortcut to achieving practical fusion energy — an advance that, if validated and scaled, could accelerate the arrival of abundant, low-carbon power. This article explains the science, the promise, the technical hurdles, and what such a development would mean for energy, industry, and policy.
The One Workout Older Adults Need to Lose Fat and Preserve Muscle
A concise guide explaining why a specific full‑body resistance workout outperforms other approaches for older adults who want to lose fat while keeping — or even rebuilding — muscle, with practical programming, safety tips, and a 12‑week plan.
Epilepsy Drug Shows Promise to Reverse Osteoarthritis Damage
Preclinical research suggests that FDA‑approved anti‑epileptic medications that target specific ion channels can slow, and in some animal models partially reverse, osteoarthritis cartilage damage. Scientists are exploring repurposing these drugs — with cautious optimism — as disease‑modifying therapies while clinical testing is planned or underway.
Dual-Action Therapy Targets Lung Cancer and Muscle Wasting
Scientists describe a promising dual-action approach that suppresses lung tumor growth while preventing cancer-associated muscle wasting (cachexia) in early studies, offering hope for stronger, longer lives for patients if clinical trials confirm the benefits.
Breakthrough Method Makes Hydrogen from Water Faster
Researchers report a laboratory advance that lowers the energy needed to split water, offering a practical path toward cheaper, greener hydrogen. The development could accelerate decarbonization—if it scales and proves durable outside the lab.
How a Common Vitamin Might Help Fight Deadly Glioblastoma
Emerging research suggests that high-dose (intravenous) vitamin C—pharmacologic ascorbate—may sensitize glioblastoma to radiation and chemotherapy and directly damage tumor cells through pro‑oxidant mechanisms; the approach is investigational, with early-phase trials under way and important safety considerations.